GBS is CRO also focused on participating in and performing large cohorts population and clinical observational studies that aim to identify circulating biomarkers for the occurrence of disease and as well as discovery of circulating prognostic factors that alter the outcomes of disease.

• ● Assessing feasibility
• ● Selecting the most appropriate readouts, biomatrices and functional assays
• ● Awareness of pre-analytical requirements
• ● Sourcing additional samples¨Iterative study plans
• ● Identifying most cost-effective solutions

• ● Protocols for sample collection, including sample collection kits
• ● Serum/plasma processing
• ● Cell isolation
• ● DNA/RNA isolation
• ● 24/7 monitored facilities and equipment

• ● ELISA based platforms
• ● Multiplex  platform
• ● Enzymatic activity assays
• ● Functional cell-based assays
• ● Biochemical assays
• ● Flow cytometry, cell separation
• ● Mitochondrial function
• ● Assay validation and performance reported by FDA/EMA guidelines
• ● Data formatted to your database requirements

• ● Software and statistical support
• ● Data interpretation
• ● Pre-validation and final reports
• ● Publication support

Our know-how approach and flexibility ensures tailoring of the screening method to accommodate the novel approaches for obtaining, storing and analyzing data through biomedical informatics making GBS valuable and reliable partner to any inter-disciplinary collaborative project.